companies / pavmed-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-07 json
| total_raised | 1,800,0001.8M | ○ |
|---|---|---|
| founded | 2014 | |
| hq | new york, ny, usa | |
| industry | unknown | |
| stage | null |
PavMed is a publicly-traded medical-device incubator developing minimally invasive devices and diagnostics across multiple specialties. It serves hospitals, ASCs, and physicians needing alternatives to incumbent device categories. Its diversified pipeline (CarpX, EsoCheck, EsoGuard) shares regulatory and commercial infrastructure across products, where single-product device startups must rebuild for each indication.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2024-01-01 | grant | 1,800,0001.8M | null | ○ |
| fact | status | src |
|---|---|---|
| Grant, $1.8M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |